ProductsPricingResearchSupportPartner

Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund

Fund Comparison

Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis

Fund Details

Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.25
1.96
NAV
₹289.36
₹421.68
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1167.75 Cr
₹3202.66 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days

Risk

Very High
Very High

Rating

3.0
4.0

Min SIP Amount

₹500
₹500

Expense Ratio

2.25
1.96

NAV

₹289.36
₹421.68

Fund Started

01 Aug 2005
04 Jun 1999

Fund Size

₹1167.75 Cr
₹3202.66 Cr

Exit Load

Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days

Returns

1 Year
56.86%
50.53%
3 Year
19.27%
21.63%
5 Year
29.22%
30.20%

1 Year

56.86%
50.53%

3 Year

19.27%
21.63%

5 Year

29.22%
30.20%

Holding Analysis

Equity
97.48%
96.24%
Cash
2.41%
3.76%

Equity

97.48%
96.24%

Cash

2.41%
3.76%

Top Holdings

Top 10 Holdings
Name
Assets
Sun Pharmaceutical Industries Ltd.
11.47%
Cipla Ltd.
6.65%
Ajanta Pharma Ltd.
5.56%
Dr. Reddy's Laboratories Ltd.
5.24%
Apollo Hospitals Enterprise Ltd.
3.84%
Glenmark Pharmaceuticals Ltd.
3.71%
Eris Lifesciences Ltd.
3.54%
Aurobindo Pharma Ltd.
3.36%
Procter & Gamble Health Ltd.
3.31%
Fortis Healthcare Ltd.
3.00%
Name
Assets
Sun Pharmaceutical Industries Ltd.
11.94%
Divi's Laboratories Ltd.
5.73%
Lupin Ltd.
5.60%
Max Healthcare Institute Ltd.
5.44%
Cipla Ltd.
5.17%
Lonza Group Ag
5.13%
Poly Medicure Ltd.
4.66%
Krishna Institute of Medical Sciences Ltd
3.95%
Aether Industries Ltd.
3.89%
Jupiter Life Line Hospitals Ltd.
3.76%

Top 10 Holdings

Name
Assets
Sun Pharmaceutical Industries Ltd.
11.47%
Cipla Ltd.
6.65%
Ajanta Pharma Ltd.
5.56%
Dr. Reddy's Laboratories Ltd.
5.24%
Apollo Hospitals Enterprise Ltd.
3.84%
Glenmark Pharmaceuticals Ltd.
3.71%
Eris Lifesciences Ltd.
3.54%
Aurobindo Pharma Ltd.
3.36%
Procter & Gamble Health Ltd.
3.31%
Fortis Healthcare Ltd.
3.00%
Name
Assets
Sun Pharmaceutical Industries Ltd.
11.94%
Divi's Laboratories Ltd.
5.73%
Lupin Ltd.
5.60%
Max Healthcare Institute Ltd.
5.44%
Cipla Ltd.
5.17%
Lonza Group Ag
5.13%
Poly Medicure Ltd.
4.66%
Krishna Institute of Medical Sciences Ltd
3.95%
Aether Industries Ltd.
3.89%
Jupiter Life Line Hospitals Ltd.
3.76%

Fund Manager

Name
Kamal Gada
Tanmaya Desai
Start Date
02 May 2022
27 Jun 2011

Name

Kamal Gada
Tanmaya Desai

Start Date

02 May 2022
27 Jun 2011

About Fund

Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999

Description

The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Launch Date

01 Aug 2005
04 Jun 1999